Neuropace Inc (NPCE) Q4 2025 Earnings Call Transcript

Why It Matters

The results show NeuroPace moving toward sustainable profitability while positioning a potentially large IGE market and AI‑driven software services that could broaden its addressable patient base.

Key Takeaways

• Q4 revenue $26.6M, up 24% YoY
• RNS system sales rose 26% to $22.4M
• Adjusted EBITDA turned positive at $0.9M
• PMA supplement filed for IGE, 77% seizure reduction
• SeizureID AI tool slated for 2026 cloud launch

Pulse Analysis

NeuroPace’s Q4 performance underscores a maturing commercial engine anchored by the RNS system. Adoption at level‑four epilepsy centers accelerated, pushing RNS revenue up 26% and lifting overall gross margins above 77%. Operating leverage improved as expense growth lagged revenue, delivering positive adjusted EBITDA for the second straight quarter and bolstering cash reserves above $60 million. This disciplined scaling signals a transition from pure device sales to a more diversified, high‑margin business model.

The regulatory filing for an idiopathic generalized epilepsy (IGE) indication could unlock a sizable, underserved patient cohort. The PMA supplement, supported by a 77% median seizure‑rate reduction in the Nautilus trial, benefits from Breakthrough Device designation, expediting FDA interaction. If approved, IGE expansion would add a new revenue stream beyond the core focal‑epilepsy market, enhancing the company’s growth runway and potentially reshaping treatment standards for drug‑resistant epilepsy.

Beyond hardware, NeuroPace is leveraging its 24 million intracranial EEG recordings to launch AI‑driven services. The SeizureID platform, slated for a 2026 cloud rollout, promises to cut clinician review time and improve workflow efficiency, while remote‑care capabilities aim to reduce patient travel and increase physician capacity. These software extensions create recurring revenue opportunities, deepen the data moat, and position NeuroPace as a full‑stack neuromodulation provider. Together, the hardware growth, regulatory progress, and AI initiatives set the stage for a transformational 2026.